Keith Katkin

Affiliations

  • Director at Rigel Pharmaceuticals Inc (RIGL), 2021-05-22
  • at Syndax Pharmaceuticals Inc (SNDX), 2021-02-05
  • Director at Novus Therapeutics Inc. (NVUS), 2020-09-16
  • Peo;ceo/urovant Sciences, Inc. at Urovant Sciences Ltd. (UROV), 2020-02-21
  • Director at Carbylan Therapeutics Inc. (CBYL), 2015-08-05
  • President And Ceo at Avanir Pharmaceuticals Inc. (AVNR), 2014-12-18
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AVNR $2.61 10,000 Officer, Director 327,857 2012-03-06 Filing
AVNR $0.44 14,100 Officer, Director 593,442 2009-02-24 Filing
AVNR $0.43 900 Officer, Director 579,342 2009-02-24 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
UROV $12.78 120,000 Officer, Director 0 2019-12-09 Filing
AVNR $16.93 62,520 Officer, Director 914,249 2014-12-17 Filing
AVNR $16.95 195,160 Officer, Director 976,769 2014-12-15 Filing
AVNR $16.95 20,000 Officer, Director 976,769 2014-12-15 Filing
AVNR $11.76 27,567 Officer, Director 732,845 2014-10-24 Filing